作者: Dirk Usener , Annika Hagendorf , Julia Schnieders , Ahmed Youssef , Martina Kirsch
DOI:
关键词:
摘要: The present invention provides stable pharmaceutical antibody formulations, including liquid drug product formulations and lyophilized comprising an IgG4 binding agent a citrate buffer, wherein the pH of formulation is at or below both 6 pI agent. can be used in treatment chronic bowel diseases rheumatoid arthritis.